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Abstract
Background:  Castleman's disease is a rare lymphoproliferative syndrome. Its etiology and
pathogenesis are unclear. The disease can be occasionally associated with a paraneoplastic
pemphigus (PNP), an autoimmune mucocutaneous disorder commonly seen in neoplasms of
lymphocytic origin.
Case presentation: We present a case of a 63-year old male patient who was referred for
surgical treatment of a lately diagnosed retroperitoneal pelvic mass. The patient had been already
treated for two years due to progressive diffuse cutaneous lesions histologically consistent with
lichen ruber verucosus and pemphigus vulgaris. Intraoperatively a highly vascularized solid mass
occupying the small pelvis was resected after meticulous vascular ligation and hemostasis. After
surgery and following immunosuppressive treatment a clear remission of the skin lesions was
observed.
Conclusion: Castleman's tumor should be always suspected when a retroperitoneal mass is
combined with PNP. In a review of the literature we found 37 additional cases. Complete surgical
resection of the tumor can be curative in most of the cases.
Background
Castleman's disease is a rare lymphoproliferative syn-
drome which was first described in 1956 [1]. The etiology
and pathogenesis of this entity is still unclear. The hyaline
vascular type frequently appears as a benign isolated
mediastinal or rarely retroperitoneal mass, which does
not recur after curative surgical excision. The plasma-cell
type is associated with constitutional symptoms, multi-
centric lymphnode involvement, lymphoma develop-
ment and autoimmune disease like clinical and
laboratory abnormalities, including paraneoplastic pem-
phigus (PNP) [2].
PNP is an autoimmune mucocutaneous disorder associ-
ated with neoplasms of lymphocytic origin, among them
with Castleman disease [3]. PNP can mimic a variety of
dermatological diseases including pemphigus vulgaris,
erythema multiforme, erosive lichen planus and acute
lupus erythematosus, so that the correct diagnosis is often
delayed. The role of the surgeon is essential as resection of
the tumor could be curative in many cases.
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We report a case of a patient with a retroperitoneal Castle-
man's tumor and paraneoplastic pemphigus that
improved after tumor resection. A review of the literature
is additionally presented.
Case presentation
A 63-year-old male patient was referred to our Surgical
Department from the Department of Dermatology with
the diagnosis of a large retroperitoneal pelvic tumor for
further treatment. The mass was morphologically consist-
ent with a Castleman's tumor. Patient's symptoms had
begun two years earlier with rapidly progressive diffuse
cutaneous lesions all over the trunk and extremities as
well as oral lesions with the form of erythematous plaques
and superficial hyperceratosis. Erosive mucositis with
lichenoid inflammation affecting the oral and penis
glance mucosa as well as dystrophic nails associated with
periungular erosions and onychorrexis had been
observed. The patient had been initially treated with local
corticosteroids and acitretin (Neotigason®) but skin
lesions had remained stable or had shown a mild short-
lasting remission only. The histological examination of
the lesions was consistent with lichen ruber verucosus and
pemphigus vulgaris.
One month before admission the patient was intrave-
nously treated for an atypical pneumonia and alveolitis
with Rocephin and Prednisolon (100 mg for 3 days). As
skin lesions had shown no signs of remission, further
diagnostics was initiated in order to determine a possible
paraneoplastic nature of skin pathology.
A subsequently performed contrast-enhanced multislice
CT demonstrated a highly vascularized retroperitoneal
mass (10.3 × 9.2 cm) with significant contrast enhance-
ment consistent with a sarcoma or a Castleman's tumor
(Figure 1a and 1b). The tumor filled the whole lower pel-
vis without any signs of adjacent organs' invasion though.
On physical examination besides the above mentioned
diffuse erosive muscositis with lichenoid inflammation,
no lymphadenopathy or organomegaly was noted. Preop-
erative examination of the complete blood counts
revealed the following results: hematocrite 41%, white
blood cells 11.0/nl (80% neutrophils), PTL 562 k/m, PT
90% (INR 1.07).
Following thorough preoperative diagnostics the patient
was submitted to laparotomy for resection of the tumor.
After catheterisation of both ureters with "pig-tail" cathe-
ters a midline laparotomy was performed. Entrance into
the peritoneal cavity revealed a highly vascularized solid
mass occupying the small pelvis extending to the right
iliac fossa.
After careful dissection of the right iliac vessels and right
ureter off the mass, complete excision of the bulky tumor
could be performed. Special attention was given to the
meticulous ligation of the tumor vessels, mainly collater-
als coming from the internal iliac artery, which was sepa-
rately ligated.
After surgery the patient was treated for four days on the
ICU. Postoperative course was uneventful, so that the
A). Preoperative CT scan of the abdomen showing a highly vascularized retroperitoneal tumor measuring 10 × 9.2 cm with  intratumor calcifications Figure 1
A). Preoperative CT scan of the abdomen showing a highly vascularized retroperitoneal tumor measuring 10 × 9.2 cm with 
intratumor calcifications. Right ureter dilatation (grade II), (coronal multiplanar reformation, MPR) B). The same tumor in axial 
orientation. No other tumor localization in the abdomen nor enlarged lymph nodes were detected.World Journal of Surgical Oncology 2007, 5:45 http://www.wjso.com/content/5/1/45
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patient could be referred to the Dermatology Department
for further treatment of his skin lesions. A complete eval-
uation of the patient's immune status was performed.
Main results are as following: lymphocytes 5%, CD3+
61% (reference value 59.4–84.6), CD3, CD4/CD3, CD8
0.91 % (0.9–3.6), CD3/CD19 12% (6.4–22.6), CD3/CD4
30 % (28.5–60.5), CD3/CD8 33 % (11.1–38.3), CD3/
CD16+56 23% (5.6–30.9). Anti-Desmoglein 1-Abs were
59.96 (>20 positive), anti-Desmoglein 3-Abs 48.25 (>20
positive), BP 180-Abs 6.25 U/ml (>9 positive). Skin Abs
were negative, but circulating IgG antibodies reactive with
rat urinary bladder epithelia surfaces were detected posi-
tive (diagnostic of paraneoplastic pemphigus). New histo-
logical examination of biopsies taken from skin lesions,
extremities, and the oral mucosa were consistent with the
diagnosis of lichen ruber and highly suggestive of a pem-
phigus. The latest diagnosis was confirmed with direct
immunofluorescence, which showed a high intracellular
deposition of anti-IgG (antibodies against desmosomes)
in the whole epidermis. Histological examination of the
mass revealed a Castleman tumor of hyaline vascular type
locally in sano removed.
One month after surgery the patient was newly referred to
us with a postoperative 15 × 11 cm pelvic abscess, which
was percutaneously drained under CT control. Culture of
the drained pus was positive for staphylococcus aureus
(MRSA) and an intravenous treatment was initiated (line-
zolid and flucloxacillin). Percutaneous drainage was
repeated two weeks later so that a rest fluid around the
right psoas muscle could be successfully evacuated. Due
to progression of the painful skin lesions an immunosup-
pressive treatment was initiated with cyclophosphamide
and urbason (every two weeks) and cortison daily fol-
lowed by a per os immunosuppression protocol with
cyclophosphamide and endoxan.
A dramatic improvement of the skin lesions could be seen
in a period of three weeks' time. Following a removal of
the left ureter catheter and change of the right one, the
patient could be released in a good condition with almost
complete remission of the mucocutaneous lesions four
weeks later (2 months after initial surgery).
Discussion
Castleman's tumors are neoplasms of lymphatic origin,
also known as giant lymph node hyperplasia or benign
giant lymphoma. Histologically these tumors can be clas-
sified into 3 types: a) Hyaline-vascular type (80–90%), b)
plasma cell type (10–20 %), and c) intermediate types [4].
The most common location of the tumor is the mediasti-
num (60 – 70 %). Abdominal forms are rare (10–17 %)
and the majority is being retroperitoneal. In our patient a
hyaline-vascular type with retroperitoneal location was
diagnosed. Besides the localized form multicentral vari-
ants with and aggressive clinical course, systemic symp-
toms, organomegaly and neoplastic transformation have
been reported. Castleman's disease has been associated
with a very high incidence of autoimmune phenomena
such as cytopenia, peripheral neuropathy, systemic lupus
erythematosus, Sjögren's syndrome, and myasthenia
gravis [5].
PNP is a clinically, histologically and immunologically
distinct autoimmune mucocutaneous disease. This entity
was first described by Anhalt et al. [6]. A variety of neo-
plasms have been reported in PNP. These comprise hae-
matological diseases including Non-Hodgkin
Lymphoma, chronic lymphocytic leukaemia, and Wal-
denstroems's macroglobulinaemia. More rarely there is an
association with solid tumors such as sarcoma, bronchial
carcinoma, colonic dysplasia, Castleman's disease and
thymoma [7,8]. Castleman's tumor has been found in
approximately 10 % of PNP patients [4]. The distinctive
clinical findings in PNP include severe painful oral ero-
sions and ulcerations with hemorrhagic crusting of the
lips and polymorphous skin lesions resembling erythema
multiforme, pemphigus vulgaris (PV) or lichen planus
pemphigoides [9]. These clinical findings were observed
in our patient. Cases of PNP with pulmonary involvement
resulting in respiratory failure have been also reported [9].
So it can not be excluded that the atypical pneumonia and
alveolitis of our patient could be related to the Castle-
man's tumor.
So far, it is unclear why Castleman's tumors are related to
the pathogenesis of PNP. One hypothesis is that Castle-
man's tumors' proteins function as antigens and induce
the production of autoantibodies in patients with parane-
oplastic pemphigus. Meanwhile a general propensity for
immune dysregulation has been proposed [4].
Several cases of association between pemphigus and Cas-
tleman's tumor have been reported. In a review of the eng-
lish language literature we found 37 additional cases [1-
5,7-22]. In our case the diagnosis of paraneoplastic pem-
phigus was retrospective. Initially it was described as
lichen planus in association with pemphigus. Detection
of the Castleman's tumor established the clinical correla-
tion.
Treatment of the disease depends mainly on the histolog-
ical type and the clinical symptoms [23]. Surgery arises as
the golden standard for the treatment of localized disease
with curative results in most of the cases. High doses of
corticosteroids, radiation, chemotherapy and immuno-
suppressive therapy have been used as additional thera-
peutic modalities. It should be however pointed out that
an PNP immunosuppressive treatment alone is ineffective
without treatment of the underlying neoplasm. On theWorld Journal of Surgical Oncology 2007, 5:45 http://www.wjso.com/content/5/1/45
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contrary, a complete remission of the skin lesions has
been observed once the tumor has been removed obviat-
ing the need for further immunosuppressive treatment
[3,7]. This observation emphasizes on the role of surgeons
in the treatment of the syndrome with an early and com-
plete excision of the tumor in compliance with principles
of surgical oncology. We have to point out that complete
surgical resection, although curative, is in some cases pre-
cluded due to hypervascularity of the tumor or invasion of
adjacent structures [1]. Meticulous hemostasis, protection
of major vessels and adjacent organs and complete
removal of the tumor when possible are basic surgical
principles that should be kept when operating these
tumors.
In the present case, although there was an initial deterio-
ration of skin lesions after tumor resection, the lichenoid
lesions dramatically improved after the initiation of
immunosuppressive therapy, leaving a postinflammatory
hyperpigmentation.
Conclusion
Castleman's disease is a diagnosis, which should be con-
sidered in the presence of a hypervascular tumor, what-
ever its localization. Additionally PNP should be always
considered when investigating atypical mucocutaneous
lesions such as erosive lichen planus or pemphigus vul-
garis non-responding to medication. In these cases a
prompt search for an underlying tumor should be initi-
ated. Complete surgical resection of the tumor can be cur-
ative in most of the cases.
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